AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Free cash flow

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥110.5B
P/E ratio
20.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndFree cash flow (Million JPY)YoY (%)
Mar 31, 2025-2,191-48.19%
Mar 31, 2024-4,229-2.15%
Mar 31, 2023-4,322-210.76%
Mar 31, 20223,902+247.77%
Mar 31, 20211,122-78.06%
Mar 31, 20205,115-379.51%
Mar 31, 2019-1,830-125.89%
Mar 31, 20187,069-50.14%
Mar 31, 201714,178+227.82%
Mar 31, 20164,325+329.07%
Mar 31, 20151,008

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)